Virus-Based Gene Delivery Systems
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (12) , 901-911
- https://doi.org/10.2165/00003088-200241120-00001
Abstract
Within the past decade, gene therapy strategies have come to the forefront of novel therapeutics. Tremendous advances in vector technology along with deeper understandings of vector biology and the molecular mechanisms of disease have significantly advanced the field of human gene therapy. This manuscript will discuss the viral-based subset of current gene transfer vectors. In particular, the most established viral vectors to date, including parvovirus, adenovirus, retro-virus, lentivirus, and herpesvirus-based vectors, are described, as well as the current innovative improvements being made to each. From past experience, it has become evident that in addition to optimising the vectors in terms of transgene expression, minimising vector-related immunology, and vector production, methods of vector delivery resulting in optimum vector transduction of target cells need to be established. This review will also illustrate several current improved physical delivery systems for optimal vector administration.Keywords
This publication has 131 references indexed in Scilit:
- Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patientsGene Therapy, 2000
- Multipotency of a Bone Marrow Stromal Cell Line, TBR31-2, Established from ts-SV40 T Antigen Gene Transgenic MiceBiochemical and Biophysical Research Communications, 2000
- Perflubron Enhances Adenovirus-Mediated Gene Expression in Lungs of Transgenic Mice with Chronic Alveolar FillingHuman Gene Therapy, 1999
- PERFLUOROCHEMICAL LIQUID-ENHANCED ADENOVIRAL VECTOR DISTRIBUTION AND EXPRESSION IN LUNGS OF SPONTANEOUSLY BREATHING RODENTSExperimental Lung Research, 1999
- A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, CaliforniaHuman Gene Therapy, 1998
- Helper Virus-Free Herpes Simplex Virus-1 Plasmid Vectors for Gene Therapy of Parkinson's Disease and Other Neurological DisordersExperimental Neurology, 1997
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Adeno-associated virus: integration at a specific chromosomal locusCurrent Opinion in Genetics & Development, 1993
- Infectious and Selectable Retrovirus Containing an Inducible Rat Growth Hormone MinigeneScience, 1984